ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0822

Differences in Efficacy Between Two Ultrasound-Guided Percutaneous Kidney Biopsy Techniques at a Tertiary-Care Hospital in Mexico City

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Valenzo, Alan, Hospital Juarez de Mexico, Mexico City, CDMX, Mexico
  • Garcia-Flores, Octavio Rene, Hospital Juarez de Mexico, Mexico City, CDMX, Mexico
  • Vasquez Jiménez, Enzo Christopher, Hospital Juarez de Mexico, Mexico City, CDMX, Mexico
  • Morales, Brenda, Hospital Juarez de Mexico, Mexico City, CDMX, Mexico
  • Barrientos Feria, Sarai Ruth, Hospital Juarez de Mexico, Mexico City, CDMX, Mexico
  • Figueroa Gamiño, Diana Laura, Hospital Juarez de Mexico, Mexico City, CDMX, Mexico
  • Villanueva-Perez, Arisbeth, Operadora San Angel Inn SA de CV, Mexico City, CDMX, Mexico
Background

Ultrasound-guided percutaneous renal biopsy allows for diagnosis, prognosis determination, and implementation of more precise treatments. While the standard approach is performed in the prone position using a longitudinal in-plane technique directed at the lower pole, the axial out-of-plane technique, directed towards Brödel's avascular zone, has been described as safe and effective.

Methods

A randomized, prospective, longitudinal, and analytical clinical trial was conducted from November 2025 to March 2026, in a tertiary center in Mexico City.

Results

36 participants underwent randomization at baseline, 26 met inclusion criteria: 16 in the conventional group and 10 in the axial group; 69.3% female, median age of 32.4 y, mean BMI of 26 kg/m2. The most prevalent comorbidity was hypertension 46.5%. Prior to biopsy, 46.1% of patients were on SGLT2 inhibitors. Baseline biochemical parameters showed a median serum creatinine of 2.07 mg/dL and a mean 24-hour proteinuria of 2.8 g. Nephrotic syndrome was the leading clinical indication for PRB (26.9%). A median of 2 passes (IQR 2.0–3.0) was performed per procedure across both techniques. The mean needle-to-kidney distance was greater in the conventional group (6.0 cm, IQR 5.62–7.1) compared to the out-of-plane group (4.69 cm, IQR 3.99–5.23; p=0.051). Regarding diagnostic yield, the overall median glomerular count was 21.5 (IQR 12.0–33.5). No significant difference in glomerular yield was observed between the longitudinal in-plane approach (22.5, IQR 13.0–33.0) and the axial out-of-plane approach (19.5, IQR 12.0–38.5; p=0.97). Lupus nephritis was the most frequent histopathological diagnosis (50%). 4 complications were recorded, with no significant difference in the safety profile between techniques (p=0.62).

Conclusion

Our findings demonstrate the axial out-of-plane percutaneous renal biopsy technique provides a diagnostic yield comparable to the conventional approach in a tertiary referral center. Both techniques exhibited a similar incidence of complications.

Funding

  • Government Support – Non-U.S.